| For: |
Papastergiou V, Georgopoulos SD, Karatapanis S. Treatment of |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v5/i4/392.htm |
| Number | Citing Articles |
| 1 |
Muhannad Sarem, Rodolfo Corti. Rol de las formas cocoides de Helicobacter pylori en la infección y la recrudescencia. Gastroenterología y Hepatología 2016; 39(1) doi: 10.1016/j.gastrohep.2015.04.009
|
| 2 |
Lorena Elena Meliț, Cristina Oana Mărginean, Maria Oana Săsăran. The Challenges of Eradicating Pediatric Helicobacter pylori Infection in the Era of Probiotics. Children 2022; 9(6) doi: 10.3390/children9060795
|
| 3 |
Meryem KEÇELİ BAŞARAN, Nur Şeyma ZENGİN. Can Saccharomyces boulardii treat and eradicate Helicobacter pylori among children instead of bismuth?. Journal of Health Sciences and Medicine 2022; 5(3) doi: 10.32322/jhsm.1084384
|
| 4 |
Beom Jin Kim, Hyun-Soo Kim, Hyun Joo Song, Il-Kwun Chung, Gwang Ha Kim, Byung-Wook Kim, Ki-Nam Shim, Seong Woo Jeon, Yun Jin Jung, Chang-Hun Yang, Ji Hyun Kim, Tae Ho Kim, Sang Gyun Kim, Woon Geon Shin, Sun Moon Kim, Sok Won Han, Jun Haeng Lee, Kyung Ho Kim, Sue K. Park, Byung-Joo Park, Joongyub Lee, Jae G. Kim. Online Registry for Nationwide Database of Current Trend ofHelicobacter pyloriEradication in Korea: Interim Analysis. Journal of Korean Medical Science 2016; 31(8) doi: 10.3346/jkms.2016.31.8.1246
|
| 5 |
Christine S. M. Lau, Amanda Ward, Ronald S. Chamberlain. Sequential (as Opposed to Simultaneous) Antibiotic Therapy Improves Helicobacter pylori Eradication in the Pediatric Population. Clinical Pediatrics 2016; 55(7) doi: 10.1177/0009922815601982
|
| 6 |
Yuri Costa Farago FERNANDES, Gabriel da Rocha BONATTO, Mauro Willeman BONATTO. RECURRENCE RATE OF HELICOBACTER PYLORI IN PATIENTS WITH PEPTIC ULCER FIVE YEARS OR MORE AFTER SUCCESSFUL ERADICATION. Arquivos de Gastroenterologia 2016; 53(3) doi: 10.1590/S0004-28032016000300006
|
| 7 |
Fahad Alsohaibani, Musthafa Peedikayil, Abdulaziz Alshahrani, Ali Somily, Raed Alsulaiman, Nahla Azzam, Majid Almadi. Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. Saudi Journal of Gastroenterology 2023; 29(6) doi: 10.4103/sjg.sjg_288_22
|
| 8 |
Periklis Apostolopoulos, Ioannis Koumoutsos, Konstantinos Ekmektzoglou, Panagiotis Dogantzis, Erasmia Vlachou, Chrisostomos Kalantzis, Panagiotis Tsibouris, Georgios Alexandrakis. Concomitant versus sequential therapy for the treatment ofHelicobacter pyloriinfection: a Greek randomized prospective study. Scandinavian Journal of Gastroenterology 2016; 51(2) doi: 10.3109/00365521.2015.1079646
|
| 9 |
Reka Borka Balas, Lorena Elena Meliț, Cristina Oana Mărginean. Current Worldwide Trends in Pediatric Helicobacter pylori Antimicrobial Resistance. Children 2023; 10(2) doi: 10.3390/children10020403
|
| 10 |
Mohammad Hosein Sayahi, Samira Zareei, Iqrar Ahmad, Ali Moazzam, Aynaz Khademian, Massoud Amanlou, Bagher Larijani, Maryam Mohammadi-Khanaposhtani, Mohammad Mahdavi. Design, synthesis, anti-urease activity, molecular docking, molecular dynamics, DFT analysis, and ADMET profiling of new barbiturate-phenylhydrazone-acetamide derivatives. Results in Chemistry 2026; 29 doi: 10.1016/j.rechem.2026.103679
|
| 11 |
Abhinav Nair, Madhur Joshi. Delayed retrograde jejunogastric intussusception after Roux-en-Y gastrojejunostomy: an uncommon complication in an unexpected anatomy. BMJ Case Reports 2025; 18(12) doi: 10.1136/bcr-2025-268432
|
| 12 |
Can Dolapcioglu, Mehmet Sayiner, Esra Elif Akkus, Abdulaziz Kural, Hatice Dolapcioglu, Resat Dabak, Emel Ahishali. First‐line Bismuth‐containing Five‐day Concomitant Quintuple Therapy for Helicobacter Pylori Eradication. Helicobacter 2016; 21(2) doi: 10.1111/hel.12241
|
| 13 |
Adesola Oje, Jonathan Galati, Richard M. Peek. Current Understanding of Optimal Prevention of Helicobacter pylori-Induced Cancer. Gastroenterology Clinics of North America 2025; 54(2) doi: 10.1016/j.gtc.2024.12.005
|
| 14 |
Ye Zhou, Tingzan Li, Liaqat Ali. Effects of Quadruple Therapy Combined with Probiotics on Helicobacter Pylori-Related Peptic Ulcer. Computational and Mathematical Methods in Medicine 2022; 2022 doi: 10.1155/2022/1221190
|
| 15 |
Himani Nautiyal, Imran Kazmi, Mohammed Kaleem, Muhammad Afzal, Muhammad Masood Ahmad, Ameeduzzafar Zafar, Rupinder Kaur. How Synthetic Drugs Work. 2023; doi: 10.1016/B978-0-323-99855-0.00017-8
|
| 16 |
Ding Lu, Zhen‐wei Yang, Yun‐fan Dong, Yu‐wei Zhang, Jiang Liu. Exploration of a Potential Amoxicillin MIC Threshold in Bismuth Quadruple Therapy for H. pylori Infection in Southeastern China. Helicobacter 2026; 31(2) doi: 10.1111/hel.70117
|
| 17 |
Fangyuan Dong, Danian Ji, Renxiang Huang, Fan Zhang, Yiqin Huang, Ping Xiang, Mimi Kong, Li Nan, Xianping Zeng, Yong Wu, Zhijun Bao. Multiple Genetic Analysis System-Based Antibiotic Susceptibility Testing in Helicobacter pylori and High Eradication Rate With Phenotypic Resistance-Guided Quadruple Therapy. Medicine 2015; 94(47) doi: 10.1097/MD.0000000000002056
|
| 18 |
Vasiliy Ivanovich Reshetnyak, Tatiana Magomedalievna Reshetnyak. Significance of dormant forms of <i>Helicobacter pylori</i> in ulcerogenesis. World Journal of Gastroenterology 2017; 23(27): 4867-4878 doi: 10.3748/wjg.v23.i27.4867
|
| 19 |
Fanglin Gao, Wanquan Xiang, Xiaoyan Zhang, Xiaoxing Huang, Feifei She, Yancheng Wen. Copper enhances tetracycline resistance via the efflux transporter CrdAB-CzcBA in Helicobacter pylori. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1552537
|
| 20 |
Marjan Mokhtare, Mohammad Ebrahimian, Abolfazl Namazi, Amir M. Sadeghian, Hani Talaee, Mohsen Masoodi, Jiong Yu. The Efficacy of Paraprobiotic, Probiotic, and Mineral Supplementation on the Eradication Rate of Helicobacter pylori in Patients with Dyspepsia: A Randomized Clinical Trial. Advanced Gut & Microbiome Research 2024; 2024 doi: 10.1155/2024/9936691
|
| 21 |
Osama Siddique, Anais Ovalle, Ayesha S. Siddique, Steven F. Moss. Helicobacter pylori Infection: An Update for the Internist in the Age of Increasing Global Antibiotic Resistance. The American Journal of Medicine 2018; 131(5) doi: 10.1016/j.amjmed.2017.12.024
|
| 22 |
Eskandar Hajiani, Pezhman Alavinejad, Nahid Avandi, Abdol Rahim Masjedizadeh, Ali Akbar Shayesteh. Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial. Middle East Journal of Digestive Diseases 2018; 10(4) doi: 10.15171/mejdd.2018.117
|
| 23 |
Youn I Choi, Sung Min Lee, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Sun Mi Lee, Jin-Yong Jeong, Dong Kyun Park. Therapeutic Potential of Sitafloxacin as a New Drug Candidate for Helicobacter Eradication in Korea: An In Vitro Culture-Based Study. Antibiotics 2021; 10(10) doi: 10.3390/antibiotics10101242
|
| 24 |
Zhoulin Tan, Wei Liu, Hai Liu, Cheng Li, Yan Zhang, Xia Meng, Tingting Tang, Tao Xi, Yingying Xing. Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection. European Journal of Pharmaceutics and Biopharmaceutics 2017; 111 doi: 10.1016/j.ejpb.2016.11.007
|
| 25 |
Shuanghui Luo, Wei Liu, Zhiqin Zeng, Feng Ye, Chupeng Hu, Ningyin Xu, An Huang, Tao Xi, Yingying Xing. Toxic adjuvants alter the function and phenotype of dendritic cells to initiate adaptive immune responses induced by oral Helicobacter pylori vaccines. Helicobacter 2018; 23(6) doi: 10.1111/hel.12536
|
| 26 |
Tian Geng, Zhong-Su Yu, Xi-Xi Zhou, Bo Liu, Hui-Hua Zhang, Zhong-Yue Li. Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China. European Journal of Pediatrics 2022; 181(7) doi: 10.1007/s00431-022-04456-1
|
| 27 |
Jan Rotnágl, Jiří Hložek, Richard Holý, Emil Pavlík, David Kalfeřt, Jaromír Astl. Salivary glands - a new site of Helicobacter pylori occurrence. Journal of Applied Biomedicine 2024; 22(3) doi: 10.32725/jab.2024.018
|
| 28 |
Zeriouh Meriem, Amine Elmekkaoui, Mouna Bouqfar, Abdelkrim Zazour, Wafaa Khannoussi, Ghizlane Kharrasse, Naima Abda, Zahi Ismaili. Non-Bismuth Quadruple Therapy, Sequential Therapy or High-Dose Esomeprazole and Amoxicillin Dual Therapy for First-Line Helicobacter pylori Eradication: A Prospective Randomized Study. Cureus 2020; doi: 10.7759/cureus.11837
|
| 29 |
Sotirios Georgopoulos, Vasilios Papastergiou. An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection. Expert Opinion on Pharmacotherapy 2021; 22(6) doi: 10.1080/14656566.2020.1845649
|
| 30 |
Wai Phyo Aung, Than Than Aye, Khin San Aye, Aye Mya Mya Kyaw.
Levofloxacin‐based
Helicobacter pylori
eradication in chronic dyspepsia
. GastroHep 2021; 3(6) doi: 10.1002/ygh2.478
|
| 31 |
Jun-Hyung Cho, So-Young Jin. Current guidelines for <i>Helicobacter pylori </i>treatment in East Asia 2022: Differences among China, Japan, and South Korea. World Journal of Clinical Cases 2022; 10(19): 6349-6359 doi: 10.12998/wjcc.v10.i19.6349
|
| 32 |
COMPARING THE EFFICACY OF CONCOMITANT THERAPY WITH THE STANDARD TRIPLE REGIMEN AS FIRST LINE THERAPY OF HELICOBACTOR PYLORI ERADICATION. JAIMC: Journal of Allama Iqbal Medical College 2023; 20(2) doi: 10.59058/jaimc.v20i2.38
|
| 33 |
Kamila Goderska, Sonia Agudo Pena, Teresa Alarcon. Helicobacter pylori treatment: antibiotics or probiotics. Applied Microbiology and Biotechnology 2018; 102(1) doi: 10.1007/s00253-017-8535-7
|
| 34 |
John KC Yee. <i>Helicobacter pylori</i> colonization of the oral cavity: A milestone discovery. World Journal of Gastroenterology 2016; 22(2): 641-648 doi: 10.3748/wjg.v22.i2.641
|
| 35 |
Shanmugaprakasham Selvamani, Roslinda Abd Malek, Solleh Ramli, Daniel Joe Dailin, Vijai Kumar Gupta, Dalia Sukmawati, Hala I. El-Adawi, Ong Mei Leng, Hesham Ali El Enshasy. Improvement of biomass production by Lactobacillus reuteri using double-carbon source cultivation strategy. THE 2ND SCIENCE AND MATHEMATICS INTERNATIONAL CONFERENCE (SMIC 2020): Transforming Research and Education of Science and Mathematics in the Digital Age 2021; 2331 doi: 10.1063/5.0041975
|
| 36 |
Elsa Prudent, Didier Raoult. Fluorescence in situ hybridization, a complementary molecular tool for the clinical diagnosis of infectious diseases by intracellular and fastidious bacteria. FEMS Microbiology Reviews 2019; 43(1) doi: 10.1093/femsre/fuy040
|
| 37 |
Nilanjana Das, Mangala Lakshmi Ragavan, Sanjeeb Kumar Mandal. Probiotics in the Prevention and Management of Human Diseases. 2022; doi: 10.1016/B978-0-12-823733-5.00001-5
|
| 38 |
Sophie Burtscher, Peter Krieg, Andreas Killinger, Ali Al-Ahmad, Michael Seidenstücker, Sergio Hernandez Latorre, Anke Bernstein. Thin Degradable Coatings for Optimization of Osteointegration Associated with Simultaneous Infection Prophylaxis. Materials 2019; 12(21) doi: 10.3390/ma12213495
|
| 39 |
Shria Kumar, David C. Metz, David E. Kaplan, David S. Goldberg. Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection. American Journal of Gastroenterology 2020; 115(5) doi: 10.14309/ajg.0000000000000626
|
| 40 |
Steven A. Harris, Elizabeth A. Harris, Roberta Mancuso. Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer’s Disease. Journal of Alzheimer's Disease 2015; 48(2) doi: 10.3233/JAD-142853
|
| 41 |
Mohamed Sharaf, Tehsin Ullah Khan, Chen-Guang Liu. Advance Helicobacter pylori eradication: Current therapeutic strategies and the potential of lipid-based nanocarriers for targeting receptors. Microbial Pathogenesis 2025; 209 doi: 10.1016/j.micpath.2025.108060
|
| 42 |
S Kane-Dumbre, M. Momin, P. Ravikumar, R. Khatri. DRUG DELIVERY STRATEGIES FOR HELICOBACTER PYLORI INFECTION MANAGEMENT: AN OVERVIEW. INDIAN DRUGS 2019; 56(10) doi: 10.53879/id.56.10.11811
|
| 43 |
. 2015; doi: 10.70675/097f2a3fze788z48f6z89b0zf4c45fc5b8c1
|
| 44 |
Su Young Kim, Duck Joo Choi, Jun-Won Chung. Antibiotic treatment for <italic>Helicobacter pylori</italic>: Is the end coming?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 183-198 doi: 10.4292/wjgpt.v6.i4.183
|
| 45 |
Nairita Choudhuri, Tapan Kumar Giri, Kaushik Mukherjee. Polysaccharide-based therapeutic approaches for the eradication of gastric Helicobacter pylori. International Journal of Biological Macromolecules 2026; 378 doi: 10.1016/j.ijbiomac.2026.153836
|
| 46 |
Esayas Kebede Gudina, Hiwot Amare, Solomon Ali, Melkamu Berhane Arefayine, Dagmawi Tewolde, Million Tesfaye Eshete, Mulusew Gerbaba Jebena, Andreas Wieser, Guenter Froeschl, Markos Tesfaye, Hailemichael Desalegn, Mulatu Gashaw, Alessandro Granito. Diagnostic Challenges of Helicobacter pylori Infection in Ethiopia: A Community-Based Cross-Sectional Study. Canadian Journal of Gastroenterology and Hepatology 2022; 2022 doi: 10.1155/2022/4013020
|
| 47 |
Andrea Fulgione, Nunzia Nocerino, Marco Iannaccone, Sante Roperto, Federico Capuano, Norberto Roveri, Marco Lelli, Antonio Crasto, Armando Calogero, Argenia Paola Pilloni, Rosanna Capparelli, Hélder A. Santos. Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori Infection. PLOS ONE 2016; 11(7) doi: 10.1371/journal.pone.0158646
|
| 48 |
Meltem Ayaş, Yeşim Gürol.
Antibiotic Resistance of
Helicobacter pylori
in Turkey: A Systematic Review and Meta-Analysis
. Microbial Drug Resistance 2023; 29(3) doi: 10.1089/mdr.2022.0146
|
| 49 |
Saman Alhooei, Hafez Tirgar Fakheri, Vahid Hosseini, Iradj Maleki, Tarang Taghvaei, Seyed Mohammad Valizadeh, Zohreh Bari. A Comparison between Hybrid and Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial. Middle East Journal of Digestive Diseases 2016; 8(3) doi: 10.15171/mejdd.2016.24
|
| 50 |
|
| 51 |
Nour Ibrahim, Hassan El Said, Ali Choukair. Zinc carnosine-based modified bismuth quadruple therapy <i>vs</i> standard triple therapy for <i>Helicobacter pylori </i>eradication: A randomized controlled study. World Journal of Clinical Cases 2022; 10(1): 227-235 doi: 10.12998/wjcc.v10.i1.227
|
| 52 |
|
| 53 |
Xudong Sun, Yuanyuan Xu, Fuhua Zhang, Tao Jing, Jian Han, Jinhua Zhang. Association between the IL1B −31C > T polymorphism and Helicobacter pylori infection in Asian and Latin American population: A meta-analysis. Microbial Pathogenesis 2015; 86 doi: 10.1016/j.micpath.2015.07.010
|
| 54 |
Cristian Parra-Sepúlveda, Kimberly Sánchez-Alonzo, José Becerra, Leandro Ortiz, Viviana Burgos, Cecilia Villegas, Felipe A. Sanhueza, Benjamín Oporto, Cristobal Goic, Apolinaria García-Cancino, Cristian Paz. Acid-Induced Epimerization of Eudesmin to Epieudesmin: Rapid Bactericidal and Antibiofilm Activity Against Helicobacter pylori. International Journal of Molecular Sciences 2026; 27(14) doi: 10.3390/ijms27146295
|
| 55 |
Muhannad Sarem, Rodolfo Corti. Role of Helicobacter pylori coccoid forms in infection and recrudescence. Gastroenterología y Hepatología (English Edition) 2016; 39(1) doi: 10.1016/j.gastre.2015.12.005
|
| 56 |
Kyle Higgins, Olga P. Nyssen, Joshua Southern, Ivan Laponogov, Ana Miralles Marco, Manuel Cabeza-Segura, Elena Jiménez Martí, Josefa Castillo, Mārcis Leja, Inese Poļaka, Fatima Carneiro, Ceu Figueiredo, Rui M. Ferreira, Rita Barros, Leticia Moreira, Miriam Cuatrecasas, Gloria Fernandez-Esparrach, Tamara Matysiak-Budnik, Jerome Martin, Laimas Jonaitis, Juozas Kupčinskas, Paulius Jonaitis, Mário Dinis-Ribeiro, Miguel Coimbra, Ana Carina Pereira, Filipa Fontes, Manon C. W. Spaander, Judith Honing, Stefano Sedola, Junior Andrea Pescino, Zorana Maravic, Ana Martins, Dennis Veselkov, Javier P. Gisbert, Tania Fleitas Kanonnikoff, Kirill Veselkov. The Helicobacter pylori AI-clinician harnesses artificial intelligence to personalise H. pylori treatment recommendations. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-61329-5
|
| 57 |
|
| 58 |
Marcelo Oporto, Monica Pavez, Claudia Troncoso, Alvaro Cerda, Edmundo Hofmann, Armando Sierralta, Eddy Rios, Luis Coppelli, Leticia Barrientos. Prevalence of Infection and Antibiotic Susceptibility of Helicobacter pylori: An Evaluation in Public and Private Health Systems of Southern Chile. Pathogens 2019; 8(4) doi: 10.3390/pathogens8040226
|
| 59 |
Xiao-Min Liao, Gao-Hui Nong, Mei-Zu Chen, Xue-Ping Huang, Yun-Yan Cong, Yi-Ying Huang, Bai-He Wu, Jin-Qi Wei. Modified sequential therapy <italic>vs</italic> quadruple therapy as initial therapy in patients with <italic>Helicobacter</italic> infection. World Journal of Gastroenterology 2015; 21(20): 6310-6316 doi: 10.3748/wjg.v21.i20.6310
|
| 60 |
Adrian G. McNicholl, Javier Molina‐Infante, Alfredo J. Lucendo, José Luis Calleja, Ángeles Pérez‐Aisa, Inés Modolell, Xavier Aldeguer, Margalida Calafat, Luis Comino, Mercedes Ramas, Ángel Callejo, Carlos Badiola, Jordi Serra, Javier P. Gisbert. Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double‐blind, placebo‐controlled trial. Helicobacter 2018; 23(5) doi: 10.1111/hel.12529
|
| 61 |
Zi-Han Feng, Ling Fan, Jing Yang, Xing-Yue Huo, Yan Guo, Yi Zhang, Chun-Hui Lan. Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori. BMC Microbiology 2019; 19(1) doi: 10.1186/s12866-019-1558-8
|
| 62 |
Hui Song, Xiaobo Lv, Jue Yang, Wei Liu, Huan Yang, Tao Xi, Yingying Xing. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model. Applied Microbiology and Biotechnology 2015; 99(22) doi: 10.1007/s00253-015-6705-z
|
| 63 |
Zijian Liu, Yi Liu, Yang Li, Yuyan Sun, Xiaoxiang Song, Lu Chen, Dan Zhou. Bibliometric and visualisation analyses of gastric ulcer knowledge areas and emerging trends, 2004–2024. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1530835
|
| 64 |
Chen Shaofang, Liang Huiqing, Chen Shaodong, Huang Yanping, Wan Shichuan, Huang Yanxia. Effect of Banxia Xiexin decoction on Helicobacter pylori-related peptic ulcers and its possible mechanism via the TGF-β/Smad signaling pathway. Journal of Traditional Chinese Medicine 2018; 38(3) doi: 10.1016/S0254-6272(18)30633-2
|